Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05508217
Other study ID # 2202-MAD-024-CB
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date August 22, 2022
Est. completion date December 1, 2024

Study information

Verified date January 2024
Source IVI Madrid
Contact Carlos Balmori Boticario, PhD
Phone +34 180 29 00
Email Carlos.Balmori@ivirma.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The proposed project we intend to assess the implication of the telomeric pathway in male infertility. To get this, several analyzes will be carried out: 1. Determination of the TL by means of two methods: Q-FISH and PCR. 2. Determination of sperm DNA fragmentation by tunnel technique. 3. Assess sperm maturation. Finally, the correlations between age, normality or not of the seminogram, LT, Short telomers (ST) accumulation, DNA fragmentation levels, sperm maturation and fertility, blastocyst development, and pregnancy rates will be established in search of cut-off points that can give a forecast of man´s fertility who consults on this subject.


Description:

To carry out the project, men who come to the clinic in the context of a couple fertility study and who do not have a known cause that justifies their infertility will be recruited. A clinical history will be made, and an informed consent will be given to them for their participation in the project (Annex Consents). Semen samples will be obtained on the day of oocyte fertilization and the unused part of the sample is recovered for Sperm LT determination, ST accumulation, sperm DNA fragmentation and sperm maturation.


Recruitment information / eligibility

Status Recruiting
Enrollment 204
Est. completion date December 1, 2024
Est. primary completion date October 1, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group N/A and older
Eligibility Inclusion Criteria: - Men of any age who come to IVI Madrid in the context of a couple's infertility study and who present normozoospermia or semenograms with sperm count >10mill/ml, >25% progressive motility and > 1% normal morphology. Exclusion Criteria: - Males who have suffered any acute illness in the three months prior to inclusion in the study. - Males with any known chronic disease or genetic alteration.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Spain Ivirma Madrid Madrid

Sponsors (1)

Lead Sponsor Collaborator
IVI Madrid

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary To assess the correlation between the length of the telomeres of the spermatozoa used in ICSI treatments with donor oocytes and their rate of blastocyst development. Characterisation of telomeric factors (telomere length, percentage of short telomeres, DNA damage) in men undergoing fertility treatments using donor oocytes, in order to find out whether telomeric parameters can be a predictive factor for fertility. 6 months
Secondary Methods of telomere measurement PCR and Q-FISH will be evaluated in order to assess whether the results are superimposable and to determine their advantages and disadvantages. With the proposed project we intend to assess the implication of the telomeric pathway in male infertility. To get this, several analyzes will be carried out:
1. Determination of the TL by means of two methods: Q-FISH and PCR.
6 months
Secondary Methods of telomere measurement PCR and Q-FISH will be evaluated in order to assess whether the results are superimposable and to determine their advantages and disadvantages. With the proposed project we intend to assess the implication of the telomeric pathway in male infertility. To get this, several analyzes will be carried out:
2. Determination of sperm DNA fragmentation by tunnel technique.
6 months
Secondary Methods of telomere measurement PCR and Q-FISH will be evaluated in order to assess whether the results are superimposable and to determine their advantages and disadvantages. With the proposed project we intend to assess the implication of the telomeric pathway in male infertility. To get this, several analyzes will be carried out:
3. Assess sperm maturation.
6 months
Secondary Percentage of short telomeres in samples analysed by FISH will be establish. To establish the percentage de short telomeres in the samples to know a new biomark. 6 months
Secondary To determine the sperm DNA fragmentation measured by Tunel assay and its correlation with the rate of blastocyst development. To establish the relationship of DNA fragmentation and the blastocyst development 6 months
Secondary Correlation of telomere length data with sperm DNA fragmentation levels, as well as fertilization, implantation, blastocyst development and pregnancy rate and live-birth. To know the important of telomere length and DNA fragmentation levels for sucessful treatment 6 months
Secondary To assess if there is a correlation between embryo morphokinetic parameters and telomere length, levels of sperm DNA fragmentation, BMI and paternal age. To know the male characteristics that influence the treatment 6 months
Secondary Establish an algorithm on the degree of male fertility based on different combinations with the previously collected data: telomere length, sperm DNA fragmentation, fertilization rates, blastocyst formation rate, pregnancy and live newborn. To know the male characteristics that influence the treatment 6 months
See also
  Status Clinical Trial Phase
Recruiting NCT06172504 - Ejaculation Frequency and Semen Parameters
Withdrawn NCT02431000 - Male Fertility and Sperm Cryopreservation
Completed NCT02422108 - TNFSF11 Inhibition and Fertility: a Prospective Study Phase 2
Withdrawn NCT02869425 - To Assess Effects of Arbaclofen ER Tablets Compared With Placebo on Sperm Parameters in Male Subjects With MS Phase 3
Recruiting NCT06243926 - Sperm Selection by Rheotaxis and Thermotaxis in In-Situ Handmade Microfluidics of Fluidic Walls in the Same ICSI Plate
Completed NCT01368484 - Effect of Dietary DHA Supplementation on Sperm Quality N/A
Completed NCT03153436 - The Effect of In-vitro Myoinositol Supplementation of Human Sperm on the Outcome of Cryopreservation Phase 1/Phase 2